Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2026 Volume 32 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2026 Volume 32 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

Serum vitamin D and fracture risk in children and adolescents: A systematic review and meta‑analysis highlighting age and altitude as key moderators

  • Authors:
    • Jinhua Ma
    • Bo Tang
    • Zhenjie Zhai
    • Zhancui Dang
  • View Affiliations / Copyright

    Affiliations: Department of Public Health, Qinghai University Medical College, Xining, Qinghai 810001, P.R. China, Sports Medicine Center, First People's Hospital of Xining City, Xining, Qinghai 810000, P.R. China
    Copyright: © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 332
    |
    Published online on: October 6, 2026
       https://doi.org/10.3892/etm.2026.13327
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

The present systematic review and meta‑analysis aimed to synthesize current comparative evidence to evaluate the association between serum 25‑hydroxyvitamin D [25(OH)D] levels and fracture risk in children and adolescents. Observational studies comparing serum 25(OH)D levels between pediatric fracture and non‑fracture groups were systematically searched in PubMed, Embase and Cochrane databases up to October 1, 2025. Data were pooled using random‑effects models. The primary outcomes were the mean difference (MD) in 25(OH)D levels and the odds ratio (OR) for fracture risk associated with vitamin D deficiency (≤20 ng/ml). Subgroup and meta‑regression analyses were performed to investigate heterogeneity. A total of 28 studies involving 10,479 participants were included. Meta‑analysis revealed significantly lower 25‑hydroxyvitamin D (25(OH)D) levels in the fracture group [MD: ‑1.94 ng/ml; 95% confidence interval (CI): ‑2.89 to ‑0.99; P<0.00001]. Vitamin D deficiency was associated with a 71% increased odds of fracture (OR: 1.71; 95% CI: 1.29‑2.27; P<0.0001), which remained significant after adjustment for confounders (adjusted OR: 2.41; 95% CI: 1.74‑3.34). Meta‑regression identified specific age (8.3‑9.5 years) and altitude residence (≥600 m) as core moderators explaining the heterogeneity. Vitamin D deficiency is markedly associated with an elevated fracture risk in children and adolescents, with the association being particularly pronounced in early adolescence and at ≥600 m altitudes. These findings highlighted the need for targeted screening and preventive nutritional strategies in these high‑risk subgroups.

Introduction

Fractures constitute a major public health concern in pediatrics, with 30-50% of children experiencing at least one fracture before adulthood, imposing significant clinical and economic burdens (1,2). Vitamin D is fundamental for skeletal integrity, primarily by regulating calcium and phosphate homeostasis to facilitate bone mineralization (3). Its classic deficiency leads to rickets and osteomalacia. Mounting evidence indicates that suboptimal vitamin D status, often defined as serum 25-hydroxyvitamin D [25(OH)D] <50 nmol/l (20 ng/ml), is highly prevalent globally among youth, even in sun-rich regions, with puberty being a period of heightened physiological demand (4-6).

Despite a plausible biological mechanism, the epidemiological link between vitamin D status and fracture risk in children and adolescents remains inconsistent. Recent case-control studies report conflicting findings, from a strong association to null results, potentially due to variations in study design, population characteristics [such as body mass index (BMI) or puberty], geography, and definitions of deficiency (7-9). A previous meta-analysis by Yang et al (10) synthesized evidence up to mid-2020, confirming an association but with substantial heterogeneity (I²=73.9%), partially attributed to latitude and season. Another relevant systematic review and meta-analysis published by Zheng et al (11) yielded consistent positive associations based on an updated body of literature. Since then, several new, methodologically robust studies have emerged, including investigations into specific subgroups and diverse geographical settings, which were not comprehensively addressed previously (8,9,12).

Therefore, an updated and comprehensive meta-analysis is warranted. The present study aimed to synthesize the most current evidence to: i) Re-evaluate the association between serum 25(OH)D levels and fracture risk in children and adolescents; ii) quantify the pooled odds ratio for fractures comparing individuals with vitamin D deficiency/insufficiency to those with sufficient levels using standardized thresholds; and iii) systematically explore potential sources of heterogeneity, including latitude, season, trauma energy, and age group. By incorporating recent studies and conducting thorough subgroup and meta-regression analyses, this meta-analysis provided a more precise and contemporary estimate of this association, offering crucial insights for clinical practice regarding screening and nutritional interventions in at-risk pediatric populations.

Materials and methods

Search strategies

According to PRISMA statement (13), two review authors independently conducted a systematic electronic and manual search in PubMed (https://pubmed.ncbi.nlm.nih.gov/), Cochrane (https://www.cochranelibrary.com/) and Embase (https://www.embase.com/) databases to identify observational studies that had compared the serum vitamin D levels in a population of children and adolescents with and without fracture. All the available literature without language restrictions was retrieved, with the last search made on October 1, 2025. Search terms included ‘vitamin D’, ‘25-hydroxyvitamin D2’, ‘children’ and ‘fractures’. A combination search using the subject terms (Medical Subject Heading, MeSH) and free terms was carried out. The references of these full-text assessed articles were also reviewed.

A combination search in PubMed revealed the following: (‘vitamin D’ [Title/Abstract] OR ‘vitamin D’ [MeSH Terms] OR ‘cholecalciferol’ [Title/Abstract] OR ‘hydroxycholecalciferols’ [Title/Abstract] OR ‘25 hydroxyvitamin D2’ [Title/Abstract] OR ‘dihydrotachysterol’ [Title/Abstract]) AND (‘fractures, bone’ [MeSH Terms] OR ‘fractures bone’ [Title/Abstract]) AND (‘adolescent’ [MeSH Terms] OR ‘adolescents’ [Title/Abstract] OR ‘adolescence’ [Title/Abstract] OR ‘youth’ [Title/Abstract] OR ‘youths’ [Title/Abstract] OR ‘teens’ [Title/Abstract] OR ‘teen’ [Title/Abstract] OR ‘teenagers’ [Title/Abstract] OR ‘teenager’ [Title/Abstract OR ‘pediatric’ [Title/Abstract] OR ‘child’ [MeSH Terms] OR ‘child’ [Title/Abstract] OR ‘children’ [Title/Abstract]). Corresponding search strategies adapted for Embase (Emtree thesaurus, :ti,ab field labels) and Cochrane Library (MeSH terminology, :ti,ab field labels) were developed with identical core search concepts, free-text synonyms and Boolean logic to the PubMed search string. The full search formulas for Embase and Cochrane Library are presented in Table SI.

Grey literature including clinical trial registry records, conference abstracts, dissertations and unpublished research reports was not retrieved in this meta-analysis. Most grey literature lacked complete standardized data of serum 25(OH)D and fracture outcomes and their inconsistent methodological quality would introduce substantial heterogeneity to pooled analyses and reduce the reliability of synthetic results.

The eligibility criteria

Studies were included if they met the following strict criteria: i) Compared the vitamin D level between fracture and non-fracture groups; ii) involved only children and adolescents population.

Study design

Prospective or retrospective case-control studies, cross-sectional studies.

Data extraction

For each study, two independent reviewers (BT and JM) extracted the following information: Surname of the first author, publication year, country where the study was conducted, design of the study, sample size, latitude, altitude, season, ethnicity, fracture site, trauma energy and Newcastle-Ottawa Scale (NOS).

Statistical analysis

Review Manager statistical software (version RevMan 5.4; https://revman.cochrane.org/) and R software (version 4.4.3; https://www.r-project.org/) were used to analyze all the datasets. The mean difference (MD) was used to compare measurement data. The odds ratio (OR) was calculated for counting data. Cochran's Q χ2 test was employed to assess statistical heterogeneity across studies. In accordance with the Cochrane Handbook, the selection between fixed-effect and random-effects models should not be guided by the results of statistical heterogeneity tests. The present study therefore employed the random-effects model consistently across all analyses. The heterogeneous studies were analyzed, univariate and further multivariate meta-regression analysis was performed to isolate the possible factors causing heterogeneity. For the subgroup analyses, if a study exhibited marked clinical heterogeneity (such as markedly different baseline characteristics) compared with the other studies within the same stratum, it was manually excluded from the pooled subgroup estimates to avoid misleading results. These excluded studies are clearly marked as having zero weight or labelled as ‘Not estimable’ in the corresponding forest plots, ensuring the clinical homogeneity of the specific subgroup analyses. If heterogeneity between the 2 groups was still significant, descriptive statistics were employed. All the statistical tests were two-sided. P<0.05 was considered to indicate a statistically significant difference.

Publications assessment

The methodological quality of the included studies was assessed using the NOS (14). This tool employs a ‘star system’ to appraise studies across three domains: i) The selection of study groups, ii) the comparability of groups and iii) the ascertainment of exposure (for case-control studies) or outcome (for cohort studies). Based on the total star score, studies were categorized as high quality (≥7 stars), moderate quality (5-6 stars), or low quality (≤4 stars). Two review authors independently performed the assessments, with any discrepancies resolved through discussion until consensus was reached.

Results

Selection of publications

In total, 4,987 literature sources were retrieved from PubMed, Cochrane and Embase Databases. A total of 3,046 literature articles were left for further evaluation after the removal of duplicates. 124 literatures were screened out through title and abstract evaluation, and 28 studies were finally included according to the inclusion criteria (7-9,12,15-38) (Fig. 1).

The flowchart of literature inclusion
and exclusion.

Figure 1

The flowchart of literature inclusion and exclusion.

This systematic review and meta-analysis included a total of 28 observational studies, comprising five cross-sectional and 23 case-control designs. The pooled analysis encompassed 4,135 pediatric and adolescent patients with fractures and 6,344 age- and sex-matched controls. The included studies were conducted across diverse geographical regions: Nine from the United States, three from Turkiye, two from Lebanon, two from Poland and one each from Romania, Ireland, New Zealand, China, Iran, Canada, Egypt, Jordan, Greece, Finland, Switzerland and Saudi Arabia (Table I).

Table I

Basic characteristics of included studies.

Table I

Basic characteristics of included studies.

First author/s, yearDesignCityCountryLatitudeAltitude, mSeasonSample size (n)Age, yearsSex (M/F)EthnicityFracture siteTrauma energyNOS(Refs.)
Assaf et al, 2024Case-conByblosLebanon34˚ N20May to October107Trial: 7.4± 3.7 Con: 7.8±4.6Trial: 30/7 Con: 42/28UnclearUpper and lower limbLow6(7)
Segal et al, 2023Retros case-conCincinnatiUSA39˚ N150All10315.9±2.248/55MixedMixedLow or middle7(9)
Matcovic et al, 2023Pros case-conColumbusUSA40˚ N275All856Trial: 6-17 Con: 6.7-17.6UnclearMainly WhiteDistal forearmLow or middle7(8)
Herdea et al, 2023Pros case-conBucharestRomania44˚ N70All15772-17Trial: 399/289 Con: 439/450UnclearUpper limbLow6(12)
Varkal et al, 2022Pros Case-conIstanbulTurkiye41˚ N40AllTrial: 76 Con: 509.2± 4.1 (2-18)Trial:4 8/28 Con: 24/26UnclearMixedLow6(38)
Moore et al, 2022Pros case-conDublinIreland53˚ N20AllTrial: 58 Con: 58Trial: 8.0±4.2 Con: 8.9±4.4Trial: 39/19 Con: 31/27Mainly WhiteMixedMixed6(37)
Talmac et al, 2021Pros case-conIstanbulTurkiye41˚ N40Feb to MayTrial: 50 Con: 50Trial: 8.3±2.8 (5-15) Con: 7.9 ± 3.4 (5-15)Trial: 32/18 Con: 34/16UnclearDistal radiusLow5(36)
Delshad et al, 2020 Cross-sectionalAucklandNew Zealand36˚ S200Aug6479.8±0.7 (8-12)293/354MixedMixedMainly low or middle4(35)
Liu et al, 2019Case-conShen yangChina41˚ N55AllTrial: 695 Con: 224Trial: 7.1±2.8 (1-15) Con: 7.8±3.4 (1-15)Trial: 448/247 Con: 113/111ChineseUpper limbLow or middle5(34)
Younes et al, 2019 Cross-sectionalGB and MLLebanon34˚ N50-2000May to OctoberTrial: 165 Con: 80913.37±2.92 (8-18)508/466LebaneseMixedUnclear5(33)
Popko et al, 2018Case-conBialystokPoland53˚ N120May to AugTrial: 20 Con: 19Trial: 12 (5-15) Con: 13.5 (7-17)Trial: 14/6 Con: 9/10unclearunclearLow6(32)
Ramirez et al, 2018Case-conMayaguezUSA18˚ N7Jan to JulTrial: 107 Con: 948.6±4.0 (1-18)Trial: 64/43 Con: 48/46HispanicUpper and lower limbLow4(31)
Saglam et al, 2017Case-conIstanbulTurkiye41˚ N40Jun to Aug60Trial: 8.2±2.6 Con: 7.7±2.1Trial: 18/12 Con: 14/16UnclearForearmUnclear3(30)
Minkowitz et al, 2017Case-conMorristownUSA40˚ N110UnclearTrial: 369 Con: 662Trial: 10.7±4.1 Con: 12.2±4.8530/486Mainly WhiteMixedMixed4(29)
Thompson et al, 2017Pros case-conChicagoUSA42˚ N179All120Trial: 5.8±2.8 Con: 7.5±4.4Trial: 33/27 Con: 25/35MixedMainly long boneLow5(28)
Jeddi et al, 2017 Cross-sectionalKawarIran30˚ N1600Unclear47813.7±2.6241/237IranianMixedMixed4(27)
Karpinski et al, 2017Case-conBialystokPoland53˚ N120Apr to Sep22711.6±3.7 (3-18)161/66unclearUnclearLow5(26)
Andersan et al, 2017Case-conTorontoCanada43˚ N76All5493.5±1.5 (<6)307/242Mainly WhiteUpper and lower limbLow5(25)
El-Sakka et al, 2016Pros case-conCairoEgypt30˚ N23Dec to JunTrial: 23 Con: 23Trial: 6.7±2.3 Con: 7.7±1.7Trial: 14/9 Con: 14/9EgyptianForearmUnclear5(24)
Jahmani et al, 2017Case-conAr-RamthaJordan32˚ N525Unclear1196.5±4.670/49UnclearMixedUnclear2(23)
AL-Daghri et al, 2016 Cross-sectionalRiyadhSaudi Arabia25˚ N600AllTrial: 234 Con: 1022Trial: 14.07±1.39 Con: 14.03±1.81Trial:148/86 Con:476/546Saudi ArabMixedLow or middle4(22)
Contreras et al, 2014Pros case-conWinston-SalemUSA36˚ N300Oct to JanTrial: 100 Con: 100Trial: 10.1 (9.2-11) Con: 11 (10.0-11.9)Trial: 70/30 Con: 50/50MixedMixedLow4(21)
Papaefthymiou et al, 2014Case-conAthensGreece38˚ N70AllTrial: 21 Con: 42Trial: 14.10±2.15 Con: 13.47±2.12All maleGreekMixedTraumatic4(20)
Mäyränpää et al, 2012Pros case-conHelsinkiFinland60˚ N10AllTrial: 66 Con: 64Trial: 10.7 (4.4-16.8) Con: 11.2Trial: 44/22 Con: 43/21Mainly FinnishMixedLow6(19)
Ryan et al, 2012Case-conWashington DCUSA39˚ N125AllTrial: 70 Con: 71Trial: 6.9±1.4 Con: 7.0±1.5Trial: 44/32 Con: 40/34African AmericanForearmLow5(18)
Ceroni et al, 2012Pros cross-sectionalGenevaSwitzerland46˚ N375UnclearTrial1: 50 Trial2: 50 Con: 50Trial1: 12.9±1.7 Trial2: 3.0±1.7 Con: 12.7±2.3UnclearSwiss CaucasianAppendicularLow or middle5(17)
Olney et al, 2008Case-conJacksonvilleUSA40˚ N5UnclearTrial: 68 Con: 57Trial: 12.0±3.0 Con: 11.1±3.2Trial:48/20 Con: 34/23Mainly WhiteMixedLow4(16)
Chan et al, 1984Case-conSLCUSA30˚ N1300UnclearTrial: 17 Con: 17Trial: 6.4±0.8 Con: 6.4±0.8Trial: 9/8 Con: 9/8UnclearlimbAccidental4(15)

[i] pros, prospective; retros, retrospective; con, control; NOS, Newcastle-Ottawa Scale; SLC, Salt Lake City; GB, Great Beirut; ML, Mount Lebanon.

Quality assessment of included studies

Based on the NOS ‘star system’, the 28 included studies were predominantly moderate in methodological quality. Specifically, two studies achieved a rating of seven stars, six received six stars, nine were assessed as five stars, another nine as four stars, while one study was rated three stars and one two stars. Notably, a primary factor contributing to the relatively lower NOS scores in certain studies was insufficient documentation of seasonal factors, particularly the unclear comparability of vitamin D blood sampling seasons between the fracture and non-fracture groups. This methodological limitation consequently diminished the overall methodological rigor and the reliability of their respective findings.

Egger test and funnel plot for publication bias

The results of Egger's linear regression test indicated that the intercept term was not statistically significant (P=0.53; 95% CI: -2.16 to 1.08), suggesting no significant asymmetry in the funnel plot and thus no evidence of substantial publication bias. Through a combination of funnel plot visualization and Egger's test, the present study did not detect significant publication bias, indicating a low risk of bias among the included studies and supporting the reliability of the pooled effect estimate (Fig. 2).

Funnel plot for publication bias.

Figure 2

Funnel plot for publication bias.

Sensitivity analysis

The sensitivity analysis results of the present study demonstrated that upon the sequential removal of any single study, the direction and statistical significance of the pooled effect size remained unchanged, with minimal fluctuation in heterogeneity (<5%; Fig. 3). Leave-one-out sensitivity analysis included low-quality studies rated two or three stars; sequential individual omission of each low-quality study did not materially change the pooled effect estimate or its statistical significance. This indicates that the core conclusion of the present study, that adolescents in the fracture group have significantly lower vitamin D levels than those in the control group (pooled MD~ -1.95), exhibits good robustness and is not unduly influenced by individual studies. Even after excluding the studies with the largest sample sizes [such as Herdea 2023(12), Matcovic 2023(8)], the pooled effect size remained stable (MD=-1.78 to -1.94), indicating that large-sample studies did not disproportionately influence the overall results. This minimized the risk of ‘weight bias’ interfering with the conclusions. In summary, the findings of this meta-analysis were robust and reliable. The core conclusions possess strong external validity and can provide stable evidence to support clinical practice and public health decision-making.

Leave-one-out meta-analysis for
sensitivity analysis. MD, mean difference; CI, confidence interval;
Tau2, Tau-squared; I2, I-squared.

Figure 3

Leave-one-out meta-analysis for sensitivity analysis. MD, mean difference; CI, confidence interval; Tau2, Tau-squared; I2, I-squared.

Comparison of serum vitamin D levels between the fracture and the non-fracture groups

A total of 27 studies involving 10,433 adolescent participants were included, comprising 4,112 in the fracture group and 6,321 in the non-fracture group. The mean vitamin D levels ranged from 12.28-35.4 ng/ml in the fracture group and from 15.08-36.64 ng/ml in the non-fracture group. Considerable variation in sample sizes was observed across studies, with the smallest study including 34 participants [Chan 1984(15)] and the largest including 1,577 [Herdea 2023(12)]. Study weights were evenly distributed (range: 3.1-5.0%), indicating that no single study unduly influenced the pooled results. Three studies [Contreras 2014(21), Younes 2019(33), Segal 2023(9)] reported slightly higher vitamin D levels in the fracture group compared to the non-fracture group. However, the effect sizes were small (MD=0.10-2.72), and only the result from Younes 2019 reached statistical significance (MD=1.29; 95% CI: 0.15-2.43). The overall effect of these studies on the pooled results was limited. Meta-analysis revealed that the mean vitamin D level was significantly lower in the fracture group than in the non-fracture group (MD=-1.94 [-2.89-0.99]; P<0.00001; I2=80%). However, this finding requires cautious interpretation due to significant heterogeneity (Fig. 4).

Pooled results of serum vitamin D
levels between the fracture and the non-fracture groups. SD,
standard deviation; IV, inverse variance; CI, confidence
interval.

Figure 4

Pooled results of serum vitamin D levels between the fracture and the non-fracture groups. SD, standard deviation; IV, inverse variance; CI, confidence interval.

Comparison of risk of serum vitamin D deficiency between the fracture and the non-fracture groups

A total of 17 studies, comprising 5,473 adolescent participants (2,488 in the fracture group and 2,985 in the non-fracture group), were included in this analysis on the correlation of vitamin D deficiency (vitamin D level ≤20 ng/ml) with fracture (Fig. 5). Within these studies, vitamin D deficiency was reported in 1,620 participants from the fracture group and 1,894 from the non-fracture group. The distribution of study weights varied, with the highest weight assigned to Herdea 2023(12) (34.9%) and the lowest to Saglam 2017(30) (0.5%). Importantly, no single study contributed >50% of the total weight, thus mitigating the risk of any individual study exerting undue influence on the pooled result. Of the 17 studies, 13 reported a positive association between vitamin D deficiency and fracture risk in adolescents (OR>1), with eight reaching statistical significance, the strongest effect was observed in the study by Saglam et al (30) (OR=13.14; 95% CI: 3.84-45.02), indicating a 13.14-fold higher fracture risk among adolescents with vitamin D deficiency in that study. The studies with the highest statistical weights, Herdea 2023(12) (OR=2.42; 95% CI: 1.94-3.01) and Liu 2019(34) (OR=1.78; 95% CI: 1.30-2.45); both supported the conclusion that vitamin D deficiency increases fracture risk, further validating the robustness of the pooled result.

Pooled OR for fracture risk in
vitamin D deficiency (vitamin D level ≤20 ng/ml). OR, odds ratio;
M-H, Mantel-Haenszel; CI, confidence interval; Tau², Tau-squared;
Chi², Chi-squared; df, degrees of freedom; I², I-squared; Z,
Z-statistic.

Figure 5

Pooled OR for fracture risk in vitamin D deficiency (vitamin D level ≤20 ng/ml). OR, odds ratio; M-H, Mantel-Haenszel; CI, confidence interval; Tau², Tau-squared; Chi², Chi-squared; df, degrees of freedom; I², I-squared; Z, Z-statistic.

The pooled analysis revealed that adolescents with vitamin D deficiency (vitamin D level≤20 ng/ml) had a significantly higher risk of fracture compared to those with sufficient vitamin D levels (OR=1.71 [1.29-2.27]; P<0.0001; I²=65%). This result indicates that vitamin D deficiency is associated with a 71% increased risk of fracture in adolescents, confirming a significant positive association between vitamin D deficiency and fracture risk in this population. Similarly, this result should be interpreted with caution owing to substantial heterogeneity (Fig. 5).

Building upon the previous unadjusted analyses, the present study further incorporated studies that explicitly reported adjusted ORs to focus on the independent association between vitamin D deficiency and fracture risk in adolescents. Statistical analysis was performed using the metafor package in R software version 4.4.3 (https://www.r-project.org/). Adjusted ORs with their corresponding 95% CI served as the core effect measure to evaluate the strength of the independent association. The pooled analysis demonstrated that, even after adjusting for potential confounders, vitamin D deficiency remained significantly associated with an increased risk of fracture [OR=2.41 (95% CI: 1.74-3.34); P<0.0001; I²=11.11%; P=0.3373; Fig. 6]. This result suggested that, independent of confounding factors such as age and altitude, adolescents with vitamin D deficiency face a 2.41 times higher risk of fracture compared to those with sufficient levels, further confirming the independence and robustness of this association.

Pooled adjusted OR for fracture risk
in vitamin D deficiency (vitamin D level ≤20 ng/ml). SE, standard
error; IV, inverse variance; CI, confidence interval; Tau²,
Tau-squared; Chi², Chi-squared; df, degrees of freedom; I²,
I-squared.

Figure 6

Pooled adjusted OR for fracture risk in vitamin D deficiency (vitamin D level ≤20 ng/ml). SE, standard error; IV, inverse variance; CI, confidence interval; Tau², Tau-squared; Chi², Chi-squared; df, degrees of freedom; I², I-squared.

Univariate and multi-variate meta-regression analysis on the heterogeneity

Given the considerable number of original studies, the present study further conducted meta-regression to explore sources of heterogeneity. Metafor package in R software was mainly employed to perform the univariate regression analysis, the results demonstrated that age, altitude, latitude, and season could markedly explain the heterogeneity (Table II). Subsequent multivariate meta-regression indicated that a model combining age and altitude sufficiently accounted for the heterogeneity, while latitude and season also contributed partially to explaining its sources (Table III). The two variables with the strongest explanatory power in the univariate analysis (age and altitude, both accounting for 100% of the heterogeneity) remained capable of fully explaining the heterogeneity within the multivariate core model, confirming their central moderating roles. Variables with weaker explanatory power in the univariate analysis (such as Study design and Trauma energy) were not included in the multivariate model. Since the core model already explained 100% of the heterogeneity, the addition of Latitude and Season did not alter the model's explanatory power or the AIC value, indicating that these variables are either collinear with the core variables (age/altitude) or that their moderating effects are encompassed by the core variables.

Table II

Univariate meta-regression analysis on the heterogeneity.

Table II

Univariate meta-regression analysis on the heterogeneity.

Variable/subgroupCoefficient (β)Explained heterogeneity, %Standard errorQ-Model test P-value
Age, years    
     8.3-6.101002.160.0048
     9.5-5.811002.490.0191
     13.372.231000.640.0005
     15.93.661001.510.0151
Altitude, m    
     ≥600-2.281000.610.0002
     120-3.181001.070.0031
     40-2.961001.390.0329
Latitude, ˚N    
     >40-5.1894.181.940.0076
     ≤40-1.4194.181.340.2930
Season    
     May-Oct-15.2564.842.850.0001
     Dec-Mar1.5964.843.950.6880
Study design    
     Case-control0.3226.420.490.5140
     Cross-sectional-0.1826.420.530.7330
Trauma energy low-0.4531.930.380.2370
Newcastle-Ottawa Scale-0.020.310.070.7891
Fracture site: Upper limb-0.5729.070.410.1640

[i] Age and altitude subgroups were defined based on the values reported in the original studies, grouped by similar ranges: Age subgroups-8.3 years (≤9 years), 9.5 years (9-11 years), 13.37 years (12-14 years) and 15.9 years (≥15 years); altitude subgroups-40 m (≤76 m), 120 m (110-200 m) and ≥600 m (≥275 m).

Table III

Multi-variate meta-regression analysis on the heterogeneity.

Table III

Multi-variate meta-regression analysis on the heterogeneity.

ModelHeterogeneity explained, %Number of studiesResidual heterogeneity, %Q-Model test P-valueAkaike Information Criterion value
Core model (age + altitude)100270<0.0001105.6369
Core + latitude model100270<0.0001105.6369
Core + latitude + season model100270<0.0001105.6369

The multivariate regression model further delineated the specific moderating effects of age and altitude, the age groups of 8.3 and 9.5 years were identified as high-risk periods for fracture (β=-6.1; P=0.0048; and β=-5.81, P=0.0191, respectively), indicating that the association between vitamin D deficiency and fracture risk is significantly stronger in these age groups compared to others. For ≥600 m altitude regions, the regression coefficient was β=-2.28 (P=0.0002), indicating a stronger correlational pattern linking vitamin D deficiency and fracture risk among adolescents living aforementioned 600 m, alongside observations of higher fracture prevalence in this subgroup.

Subgroup analyses

To explore potential sources of heterogeneity, the present study conducted prespecified subgroup analyses using random-effects models, stratified by latitude, season/month, trauma energy and study design (Figs. S1, S2, S3 and S4). All forest plots present subgroup analyses performed using a random-effects model. Studies exhibiting substantial clinical heterogeneity within the same stratum were manually excluded from the pooled estimates; these excluded studies are displayed with zero weight or labelled as ‘not estimable’ in the respective plots.

In the latitude-based analysis, studies at ≤40 ˚N showed no significant fracture benefit from vitamin D after excluding Al-Daghri 2016(22) (unique Saudi ethnicity) and Matcovic 2023(8) (distal forearm fractures only), with heterogeneity dropping from 74-44% (P=0.73). Conversely, among studies at >40˚N, excluding Herdea 2023(12) (pandemic period), Mäyränpää 2012(19) (60˚N; low winter sunlight) and Talmac 2021(36) (February-May) reduced heterogeneity from 78-47%, and revealed a significant protective effect of vitamin D on fractures (P<0.00001).

In the seasonal subgroup analysis (18 of 27 studies with clear seasonal data), studies conducted from May to October showed a significant fracture benefit after excluding Delshad 2020 (Southern Hemisphere) and Younes 2019 (wide altitude range), with heterogeneity falling from 87-0% (P<0.00001). In the December-April subgroup, after removing Talmac 2021(36) (late winter/early spring, lowest solar radiation) and extreme exposure conditions, heterogeneity decreased from 93-0%, with no significant fracture benefit (P=0.41). In the full-year subgroup, excluding Herdea 2023(12) (pandemic) and Segal 2023(9) (age up to 15.9 years) reduced heterogeneity from 61-46% and showed a significant effect (P<0.00001).

In the trauma energy stratification (24 studies with clear energy data), the low-energy subgroup showed reduced heterogeneity from 79-38% after excluding seasonally or temporally conflicting studies (P=0.01). The low-or-moderate subgroup exhibited a marked fracture benefit, with heterogeneity dropping from 72-0% (P<0.00001). The mixed-energy subgroup (three studies) showed 0% heterogeneity and no significant benefit (P=0.57), and the unintentional injury subgroup (two studies) also showed 0% heterogeneity and no significant benefit (P=0.35).

In the study design analysis, cross-sectional studies demonstrated significant fracture risk reduction after excluding the two largest studies, which were the primary sources of heterogeneity; heterogeneity decreased from 87-0% (P=0.03).

Discussion

The main finding of the present systematic review and meta-analysis was that children aged 8.3-9.5 or those residing at altitudes (≥600 m) were at higher fracture risk. Univariate regression results indicated that age and altitude are complete explanatory factors for heterogeneity, capable of eliminating all heterogeneity independently. This finding was strongly supported by recent large-scale epidemiological studies and aligns with the physiology of skeletal development and geographical influences on vitamin D synthesis. Adolescents aged 8.3-9.5 years are in a peak period of bone growth, where the skeletal demand for vitamin D increases sharply. Vitamin D deficiency during this stage directly impairs calcium absorption and bone mineralization, leading to reduced bone strength and consequently amplifying fracture risk. Therefore, the strong negative moderating effect observed for specific ages ~9 years likely captures the beginning of this critical high-risk window. Although the absolute between-group disparities in serum 25(OH)D levels identified in this meta-analysis appear modest, with a pooled weighted mean difference of -1.94 ng/ml (95% CI: -2.89 to -0.99), such minor differences carry clear clinical relevance for pediatric and adolescent populations experiencing rapid bone turnover. Small shifts in circulating 25(OH)D can shift the overall population distribution of vitamin D status, raising the share of youth meeting clinical thresholds for insufficiency or deficiency. Within the growing skeleton, sustained subtle deficits in vitamin D correlate with gradual reductions in calcium absorption efficiency and slowed bone mineral accrual over childhood and adolescence. For the high-risk subgroups highlighted in the present study, children aged 8.3-9.5 years and adolescents living at altitudes ≥600 m, these modest disparities collectively correspond to altered fracture risk patterns at a population level, reinforcing the clinical value of targeted vitamin D monitoring and preventive supplementation for these vulnerable groups. A large Brazilian study involving >413,000 children and adolescents demonstrated a clear inverse relationship between age and vitamin D status. The prevalence of deficiency [25(OH)D <20 ng/ml] was lowest in children <2 years (4.5%) and increased progressively with age, peaking at 18.4% in adolescents (11-18 years). Notably, among female adolescents, the deficiency rate reached 20.1%, and in a high-risk subset (southern region, winter months), it soared to 36%, with 5% experiencing severe deficiency (<12 ng/ml) (39). This pattern is corroborated by the study by Yang et al (40), which found that children aged 6-8 years had the highest vitamin D levels and sufficiency rates, while levels markedly declined in older age groups.

Girls may experience an earlier onset of the pubertal growth spurt, a period of rapid bone elongation where mineralization may lag behind, temporarily increasing bone fragility. Concurrently, lifestyle factors such as greater use of sunscreen, more indoor-oriented activities, and potentially lower dietary calcium intake may exacerbate vitamin D deficiency. However, the association between vitamin D status and fracture risk among female adolescents has shown considerable heterogeneity across studies. The study by Delshad et al (35) provided more detailed insights, indicating that while high sugar-sweetened beverage intake and family history of osteoporosis were the primary predictors of fractures in girls, the association between vitamin D levels and fracture history did not reach statistical significance in this population. By contrast, the aforementioned two studies reported a higher risk profile among females (39,40). This may be explained by the fact that the direct link with fracture risk is modulated by other factors, such as calcium intake and consumption of sugar-sweetened beverages. In the present meta-analysis, due to the limited availability of stratified data reporting vitamin D levels and fracture risk by sex, it was not possible to conduct a corresponding pooled analysis to further investigate whether adolescent females indeed face a higher fracture risk compared to males.

The univariate meta-regression analysis identifies altitude (≥600 m) as a significant and independent explanatory factor for heterogeneity, accounting for 100% of the variance with a strong negative coefficient (β=-2.28; P=0.0002). The persistent vitamin D deficiency observed at high altitudes, despite increased ultraviolet B radiation, can be attributed to several interconnected factors. Studies in high-altitude populations, such as those in Saudi Arabia and the Andes, demonstrate that local environmental and lifestyle factors offset the potential benefits of elevated ultraviolet radiation, alongside a high prevalence of vitamin D deficiency in these groups (41,42). When combined with age in the multivariate model, altitude remains a core determinant, explaining all residual heterogeneity. This suggests that high-altitude residence exhibits a profound, consistent correlational link with altered vitamin D status, alongside parallel correlations with modified bone metabolism and elevated fracture risk among adolescents living in such regions. Thus, altitude should be considered a critical, independent variable in assessing vitamin D status and its health consequences in youth. The present subgroup analyses revealed that the protective association of vitamin D with fracture risk was not consistent across all strata, but was conditional on several factors, including geographic latitude, season and trauma energy. Significant effects were detected in high-latitude regions, during the May-October period, and among low to moderate-energy fractures. The observation that a significant association also emerged during sunnier months is noteworthy, as it implies that seasonal sunlight exposure alone may not fully compensate for suboptimal vitamin D status in fracture-prone populations. Michaëlsson et al (43) also supports this view, finding that individuals with insufficient accumulation of vitamin D reserves during the summer may remain deficient throughout the year, thereby increasing fracture risk. These findings support a targeted rather than universal approach to vitamin D supplementation, with consideration of latitude, season, and injury mechanism.

Notwithstanding the strong explanatory power of age and altitude in the regression models of the present study, it is acknowledged that residual unmeasured heterogeneity and multiple unadjusted confounding factors may still constrain the generalizability of the findings. First, heterogeneity originating from disparate 25(OH)D testing assays [immunoassay vs. liquid chromatography-tandem mass spectrometry (LC-MS/MS)], inconsistent trauma energy classification standards and absent stratification by fracture site could not be fully captured by the regression covariates. Second, key confounders including long-term calcium intake, daily outdoor activity volume and sugar-sweetened beverage consumption were incompletely reported and rarely uniformly adjusted across primary studies; these unbalanced covariates may interfere with the true magnitude of the vitamin D-fracture association. Additionally, insufficient sex-stratified data restricted the ability to parse sex-specific effect differences, which represents another source of residual variation that could not be eliminated in the current pooled analysis.

In summary, the present meta-analysis advanced prior syntheses by systematically identifying both age and altitude residence as core, independent moderators explaining heterogeneity in the vitamin D-fracture association among adolescents. While previous reviews have noted age or latitude as factors, the present study uniquely integrates altitude, a significant yet often neglected environmental determinant, and pinpoints a critical high-risk window (ages 8.3-9.5 years). This dual identification enables more precise risk stratification, moving beyond broad geographic generalizations. The findings underscored the necessity of context-specific public health strategies, advocating for targeted vitamin D screening and supplementation prioritization for young children and residents of high-altitude regions to mitigate fracture risk.

Several limitations of the present meta-analysis warrant consideration. The evidence primarily derived from observational, predominantly case-control studies, which are susceptible to selection bias, residual confounding and cannot establish causality. The overall quality of included studies, as assessed by the NOS, was moderate, indicating potential methodological weaknesses. Notably, substantial between-study heterogeneity existed in multiple aspects. First, 25(OH)D was measured using different laboratory assays across studies, including immunoassay and LC-MS/MS, which may introduce measurement discrepancies. Second, studies varied in the classification of trauma energy, as well as the adjustment for key confounders such as precise sunlight exposure, dietary intake and physical activity. Beyond these factors, BMI, calcium intake, outdoor activity and skin pigmentation were also insufficiently adjusted in most primary studies. Third, the majority of original studies failed to perform stratified analyses according to fracture site and trauma energy. All the aforementioned issues may have influenced the accuracy of pooled estimates. Future prospective cohort studies or well-designed trials are required to confirm the associations observed in this analysis.

In conclusion, the present meta-analysis confirmed and extended prior evidence by demonstrating a significant positive association between vitamin D deficiency and fracture risk in children and adolescents. The identification of specific age windows (8.3-9.5 years) and altitude residence (≥600 m) as key effect modifiers provides a novel framework for clinical and public health risk stratification. Despite limitations inherent to observational data, such as potential residual confounding and the inability to establish causality, these findings strongly advocated for targeted public health strategies. These include prioritized screening for vitamin D status and consideration of supplementation programs for children in early adolescence and those living in high-altitude regions. Future research should focus on prospective cohort studies to clarify causal relationships and on intervention trials to assess the efficacy of targeted vitamin D supplementation in reducing fracture incidence in these identified high-risk subgroups.

Supplementary Material

Forest plot of subgroup analysis stratified by latitude. SD, standard deviation; IV, inverse variance; CI, confidence interval; Tau2, Tau-squared; Chi2, Chi-squared; df, degrees of freedom; I2, I-squared; Z, Z-statistic.
Forest plot of subgroup analysis stratified by season. SD, standard deviation; IV, inverse variance; CI, confidence interval; Tau2, Tau-squared; Chi2, Chi-squared; df, degrees of freedom; I2, I-squared; Z, Z-statistic.
Forest plot of subgroup analysis stratified by trauma energy. SD, standard deviation; IV, inverse variance; CI, confidence interval; Tau2, Tau-squared; Chi2, Chi-squared; df, degrees of freedom; I2, I-squared; Z, Z-statistic.
Forest plot of subgroup analysis stratified by study design. SD, standard deviation; IV, inverse variance; CI, confidence interval; Tau2, Tau-squared; Chi2, Chi-squared; df, degrees of freedom; I2, I-squared; Z, Z-statistic.
Full search formulae.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The data generated in the present study may be requested from the corresponding author.

Authors' contributions

ZCD was responsible for the conception and design of the study. BT and JHM independently reviewed the full-text versions of all the articles retrieved from the literature and were responsible for the data analysis and drafting of the manuscript. ZJZ was responsible for constructing the comprehensive search strategy, performing the Newcastle-Ottawa Scale quality assessment and providing statistical support for the meta-regression analysis. JHM and ZJZ were involved in revising the manuscript critically for important intellectual content. JHM and ZJZ confirm the authenticity of all the raw data. All authors read and approved the final manuscript.

Ethics approval and informed consent

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Hedström EM, Svensson O, Bergström U and Michno P: Epidemiology of fractures in children and adolescents. Acta Orthop. 81:148–153. 2010.PubMed/NCBI View Article : Google Scholar

2 

Hailer YD, Wallin ME and Wolf O: Epidemiology and treatment of forearm fractures in Swedish children and adolescents. Eur J Trauma Emerg Surg. 51(342)2025.PubMed/NCBI View Article : Google Scholar

3 

Holick MF: Vitamin D deficiency. N Engl J Med. 357:266–281. 2007.PubMed/NCBI View Article : Google Scholar

4 

Mansbach JM, Ginde AA and Camargo CA Jr: Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: Do children need more vitamin D? Pediatrics. 124:1404–1410. 2009.PubMed/NCBI View Article : Google Scholar

5 

Cashman KD: Global differences in vitamin D status and dietary intake: A review of the data. Endocr Connect. 11(e210282)2022.PubMed/NCBI View Article : Google Scholar

6 

Weaver CM, Gordon CM, Janz KF, Kalkwarf HJ, Lappe JM, Lewis R, O'Karma M, Wallace TC and Zemel BS: The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: A systematic review and implementation recommendations. Osteoporos Int. 27:1281–1386. 2016.PubMed/NCBI View Article : Google Scholar

7 

Assaf E, Nicolas G, Hoyek F, Abi Fares G, Lahoud JC, Hajj R, Mohs E, Dally FJ, Hetjens S, Gravius S and Darwich A: Vitamin D level and low-energy fracture risk in children and adolescents: A population-based case-control study of 45 cases. J Pediatr Orthop B. 33:392–398. 2024.PubMed/NCBI View Article : Google Scholar

8 

Matkovic V, Goel P, Mobley SL, Badenhop-Stevens NE, Ha EJ, Li B, Skugor M and Clairmont A: Decreased bone mass in adolescents with bone fragility fracture but not in young children: A case-control study. Front Endocrinol (Lausanne). 14(1124896)2023.PubMed/NCBI View Article : Google Scholar

9 

Segal D, Ziv A, Meisman A, Fry J, Altaye M and Gordon CM: Relationship between hypovitaminosis D and fractures among adolescents with overweight or obesity. Clin Pediatr (Phila). 62:107–114. 2023.PubMed/NCBI View Article : Google Scholar

10 

Yang G, Lee WYW, Hung ALH, Tang MF, Li X, Kong APS, Leung TF, Yung PSH, To KKW, Cheng JCY and Lam TP: Association of serum 25 (OH)Vit-D levels with risk of pediatric fractures: A systematic review and meta-analysis. Osteoporos Int. 32:1287–1300. 2021.PubMed/NCBI View Article : Google Scholar

11 

Zheng C, Li H, Rong S, Liu L, Zhen K and Li K: Vitamin D level and fractures in children and adolescents: A systematic review and meta-analysis. J Bone Miner Metab. 39:851–857. 2021.PubMed/NCBI View Article : Google Scholar

12 

Herdea A, Ionescu A, Dragomirescu MC and Ulici A: Vitamin D-A risk factor for bone fractures in children: A population-based prospective case-control randomized cross-sectional study. Int J Environ Res Public Health. 20(3300)2023.PubMed/NCBI View Article : Google Scholar

13 

Moher D, Liberati A, Tetzlaff J and Altman DG: PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6(e1000097)2009.PubMed/NCBI View Article : Google Scholar

14 

Carra MC, Romandini P and Romandini M: Risk of bias evaluation of cross-sectional studies: Adaptation of the newcastle-ottawa scale. J Periodontal Res 28: doi: 10.1111/jre.13405, 2025.

15 

Chan GM, Hess M, Hollis J and Book LS: Bonemineral status in childhood accidental fractures. Am J Dis Child. 138:569–570. 1984.PubMed/NCBI View Article : Google Scholar

16 

Olney RC, Mazur JM, Pike LM, Froyen MK, Ramirez-Garnica G, Loveless EA, Mandel DM, Hahn GA, Neal KM and Cummings RJ: Healthy children with frequent fractures: How much evaluation is needed? Pediatrics. 121:890–897. 2008.PubMed/NCBI View Article : Google Scholar

17 

Ceroni D, de la Llana RD, Martin X, Lamah L, De Coulon G, Turcot K and Dubois-Ferriere V: Prevalence of vitamin D insufficiency in Swiss teenagers with appendicular fractures: A prospective study of 100 cases. J Child Orthop. 6:497–503. 2012.PubMed/NCBI View Article : Google Scholar

18 

Ryan LM, Teach SJ, Singer SA, Wood R, Freishtat R, Wright JL, Mc Carter R, Tosi L and Chamberlain JM: Bone mineral density and vitamin D status among African American children with forearm fractures. Pediatrics. 130:e553–e560. 2012.PubMed/NCBI View Article : Google Scholar

19 

Mayranpaa MK, Viljakainen HT, Toiviainen-Salo S, Kallio PE and Makitie O: Impaired bone health and asymptomatic vertebral compressions in fracture-prone children: A case-control study. J Bone Miner Res. 27:1413–1424. 2012.PubMed/NCBI View Article : Google Scholar

20 

Papaefthymiou MA, Bakoula C, Sarra A, Papassotiriou I, Chrousos GP and Bacopoulou F: Influence of hormonal param, bone mineral density and bone turnover on fracture risk in healthy male adolescents: A case control study. J Pediatr Endocrinol Metab. 27:685–692. 2014.PubMed/NCBI View Article : Google Scholar

21 

Contreras JJ, Hiestand B, O'Neill JC, Schwartz R and Nadkarni M: Vitamin D deficiency in children with fractures. Pediatr Emerg Care. 30:777–781. 2014.PubMed/NCBI View Article : Google Scholar

22 

Al-Daghri NM, Aljohani N, Rahman S, Sabico S, Al-Attas OS, Alokail MS, Al-Ajlan A and Chrousos GP: Serum 25-hydroxyvitamin D status among Saudi children with and without a history of fracture. J Endocrinol Invest. 39:1125–1130. 2016.PubMed/NCBI View Article : Google Scholar

23 

Jahmani R, Raffee L, Ali AMB, Alorjani M, Bashaireh KM, Ziad A and Radaideh A: Associated of vitamin D level with children fractures: A prospective cohort study. Res J Med Sci. 11:208–211. 2017.

24 

El-Sakka A, Penon C, Hegazy A, Elbatrawy S, Gobashy A and Moreira A: Evaluating bone health in Egyptian children with forearm fractures: A case control study. Int J Pediatr. 2016(7297092)2016.PubMed/NCBI View Article : Google Scholar

25 

Anderson LN, Heong SW, Chen Y, Thorpe KE, Adeli K, Howard A, Sochett E, Birken CS, Parkin PC and Maguire JL: TARGet kids collaboration. Vitamin D and fracture risk in early childhood: A case-control study. Am J Epidemiol. 185:1255–1262. 2017.PubMed/NCBI View Article : Google Scholar

26 

Karpiński M, Galicka A, Milewski R, Popko J, Badmaev V and Stohs SJ: Association between vitamin D receptor polymorphism and serum vitamin D levels in children with low-energy fractures. J Am Coll Nutr. 36:64–71. 2017.PubMed/NCBI View Article : Google Scholar

27 

Jeddi M, Dabbaghmanesh MH, Kharmandar A, Omrani GR and Bakhshayeshkaram M: Prevalence of fracture in healthy iranian children aged 9-18 years and associated risk factors; a population based study. Bull Emerg Trauma. 5:29–35. 2017.PubMed/NCBI

28 

Thompson RM, Dean DM, Goldberg S, Kwasny MJ, Langman CB and Janicki JA: Vitamin D insufficiency and fracture risk in urban children. J Pediatr Orthop. 37:368–373. 2017.PubMed/NCBI View Article : Google Scholar

29 

Minkowitz B, Cerame B, Poletick E, Nguyen JT, Formoso ND, Luxenberg SL, Lee BH and Lane JM: Morris-Essex Pediatric Bone Health Group. Low vitamin D levels are associated with need for surgical correction of pediatric fractures. J Pediatr Orthop. 37:23–29. 2017.PubMed/NCBI View Article : Google Scholar

30 

Saglam Y, Kizildag H, Toprak G, Alp NB and Yalcinkaya EY: Prevalence of vitamin D insufficiency in children with forearm fractures. J Child Orthop. 11:180–184. 2017.PubMed/NCBI View Article : Google Scholar

31 

Ramirez N, Ortiz-Fullana JL, Arciniegas N, Fullana A, Valentin P, Orengo JC, Iriarte I and Carlo S: Vitamin D levels and fracture risk among Hispanic children. Eur J Orthop Surg Traumatol. 29:531–536. 2019.PubMed/NCBI View Article : Google Scholar

32 

Popko J, Karpiński M, Chojnowska S, Maresz K, Milewski R, Badmaev V and Schurgers LJ: Decreased levels of circulating carboxylated osteocalcin in children with low energy fractures: A pilot study. Nutrients. 10(734)2018.PubMed/NCBI View Article : Google Scholar

33 

Younes N, El Hajj MA, Bizdikian AJ and Gannagé-Yared MH: An epidemiological evaluation of fractures and its determinants among Lebanese schoolchildren: A cross-sectional study. Arch Osteoporos. 14(9)2019.PubMed/NCBI View Article : Google Scholar

34 

Liu T, Wang E, Li Q and Li L: High prevalence of vitamin D insufficiency in Chinese children with upper limb fractures. Genes Dis. 7:408–413. 2019.PubMed/NCBI View Article : Google Scholar

35 

Delshad M, Beck KL, Conlon CA, Mugridge O, Kruger MC and von Hurst PR: Fracture risk factors among children living in New Zealand. J Steroid Biochem Mol Biol. 200(105655)2020.PubMed/NCBI View Article : Google Scholar

36 

Talmac MA, Gorgel MA, Varol A, Ak S, Kilinc BE and Ozdemir HM: Serum levels of vitamin D in children with or without isolated distal radius fractures: A prospective clinical study. Rev Bras Ortop (Sao Paulo). 56:351–355. 2021.PubMed/NCBI View Article : Google Scholar

37 

Moore DM, O'Sullivan M, Kiely P, Noel J, O'Toole P, Kennedy J, Moore DP and Kelly P: Vitamin D levels in Irish children with fractures: A prospective case-control study with 5 year follow-up. Surgeon. 20:71–77. 2022.PubMed/NCBI View Article : Google Scholar

38 

Varkal MA, Gulenc B, Yildiz I, Kandemir I, Bilgili F, Toprak S, Kilic A and Unuvar E: Vitamin D level, body mass index and fracture risk in children: Vitamin D deficiency and fracture risk. J Pediatr Orthop B. 31:e264–e270. 2022.PubMed/NCBI View Article : Google Scholar

39 

Radonsky V, Lazaretti-Castro M, Chiamolera MI, Biscolla RPM, Junior JV, Vieira JGH, Brandão CMA, Ramalho RF, Maeda SS and Cavichio MWE: Alert for the high prevalence of vitamin D deficiency in adolescents in a large Brazilian sample. J Pediatr (Rio J). 100:360–366. 2024.PubMed/NCBI View Article : Google Scholar

40 

Yang Y, Chen L, Ruan Y, Su W, Wan Q and Liu Z: Vitamin D status and relevant factors of children and adolescent aged 6-17 in Yunnan Province from 2016 to 2017. Wei Sheng Yan Jiu. 54:776–783. 2025.PubMed/NCBI View Article : Google Scholar : (In Chinese).

41 

Abdelsalam M, Nagy E, Abdalbary M, Alsayed MA, Ali AAS, Ahmed RM, Alsuliamany ASM, Alyami AH, Althaqafi RMM, Alsaqqa RM, et al: Prevalence and associated factors of vitamin D deficiency in high altitude region in Saudi Arabia: Three-Year retrospective study. Int J Gen Med. 16:2961–2970. 2023.PubMed/NCBI View Article : Google Scholar

42 

Mata-Greenwood E, Westenburg HCA, Zamudio S, Illsley NP and Zhang L: Decreased vitamin D levels and altered placental vitamin D gene expression at high altitude: Role of genetic ancestry. Int J Mol Sci. 24(3389)2023.PubMed/NCBI View Article : Google Scholar

43 

Michaëlsson K, Byberg L, Svennblad B, Larsson SC, Baron JA and Melhus H: Serum 25-hydroxyvitamin D is associated with fracture risk only during periods of seasonally high levels in women with a high body mass index. J Bone Miner Res. 36:1957–1966. 2020.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ma J, Tang B, Zhai Z and Dang Z: Serum vitamin D and fracture risk in children and adolescents: A systematic review and meta‑analysis highlighting age and altitude as key moderators. Exp Ther Med 32: 332, 2026.
APA
Ma, J., Tang, B., Zhai, Z., & Dang, Z. (2026). Serum vitamin D and fracture risk in children and adolescents: A systematic review and meta‑analysis highlighting age and altitude as key moderators. Experimental and Therapeutic Medicine, 32, 332. https://doi.org/10.3892/etm.2026.13327
MLA
Ma, J., Tang, B., Zhai, Z., Dang, Z."Serum vitamin D and fracture risk in children and adolescents: A systematic review and meta‑analysis highlighting age and altitude as key moderators". Experimental and Therapeutic Medicine 32.6 (2026): 332.
Chicago
Ma, J., Tang, B., Zhai, Z., Dang, Z."Serum vitamin D and fracture risk in children and adolescents: A systematic review and meta‑analysis highlighting age and altitude as key moderators". Experimental and Therapeutic Medicine 32, no. 6 (2026): 332. https://doi.org/10.3892/etm.2026.13327
Copy and paste a formatted citation
x
Spandidos Publications style
Ma J, Tang B, Zhai Z and Dang Z: Serum vitamin D and fracture risk in children and adolescents: A systematic review and meta‑analysis highlighting age and altitude as key moderators. Exp Ther Med 32: 332, 2026.
APA
Ma, J., Tang, B., Zhai, Z., & Dang, Z. (2026). Serum vitamin D and fracture risk in children and adolescents: A systematic review and meta‑analysis highlighting age and altitude as key moderators. Experimental and Therapeutic Medicine, 32, 332. https://doi.org/10.3892/etm.2026.13327
MLA
Ma, J., Tang, B., Zhai, Z., Dang, Z."Serum vitamin D and fracture risk in children and adolescents: A systematic review and meta‑analysis highlighting age and altitude as key moderators". Experimental and Therapeutic Medicine 32.6 (2026): 332.
Chicago
Ma, J., Tang, B., Zhai, Z., Dang, Z."Serum vitamin D and fracture risk in children and adolescents: A systematic review and meta‑analysis highlighting age and altitude as key moderators". Experimental and Therapeutic Medicine 32, no. 6 (2026): 332. https://doi.org/10.3892/etm.2026.13327
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team